Tenchov R, Sasso J, Zhou Q
ACS Omega. 2025; 10(2):1864-1892.
PMID: 39866628
PMC: 11755173.
DOI: 10.1021/acsomega.4c09114.
Szablewski L
Int J Mol Sci. 2025; 26(2).
PMID: 39859258
PMC: 11765393.
DOI: 10.3390/ijms26020542.
Luo X, Luo L, Lai R, Li Y, Zhou H, Li X
Nanomaterials (Basel). 2024; 14(23).
PMID: 39683350
PMC: 11643961.
DOI: 10.3390/nano14231962.
Dijkstra P, Fialkowski R, Bush B, Wong R, Moore T, Harvey A
Front Behav Neurosci. 2024; 18:1477984.
PMID: 39659705
PMC: 11628283.
DOI: 10.3389/fnbeh.2024.1477984.
Zhu L, Chen D, Wang X, He C
Mol Neurobiol. 2024; .
PMID: 39556279
DOI: 10.1007/s12035-024-04622-6.
Cohort-specific boolean models highlight different regulatory modules during Parkinson's disease progression.
Hemedan A, Satagopam V, Schneider R, Ostaszewski M
iScience. 2024; 27(10):110956.
PMID: 39429779
PMC: 11489052.
DOI: 10.1016/j.isci.2024.110956.
A Comprehensive Review on Repurposing the Nanocarriers for the Treatment of Parkinson's Disease: An Updated Patent and Clinical Trials.
Khan S, Haider M
CNS Neurol Disord Drug Targets. 2024; 24(3):181-195.
PMID: 39400019
DOI: 10.2174/0118715273323074241001071645.
Consumption of milk and other dairy products and incidence of Parkinson's disease: a prospective cohort study in French women.
Hajji-Louati M, Portugal B, Correia E, Laouali N, Lee P, Artaud F
Eur J Epidemiol. 2024; 39(9):1023-1036.
PMID: 39294525
DOI: 10.1007/s10654-024-01152-2.
Oxygen-induced stress reveals context-specific gene regulatory effects in human brain organoids.
Umans B, Gilad Y
bioRxiv. 2024; .
PMID: 39282424
PMC: 11398411.
DOI: 10.1101/2024.09.03.611030.
Association between metabolic syndrome and the risk of Parkinson's disease: a meta-analysis.
Zhong Y, Wang T, Huang L, Hua Y
BMC Neurol. 2024; 24(1):313.
PMID: 39232681
PMC: 11373127.
DOI: 10.1186/s12883-024-03820-y.
The Interplay of Carveol and All-Trans Retinoic Acid (ATRA) in Experimental Parkinson's Disease: Role of Inflammasome-Mediated Pyroptosis and Nrf2.
Muhammad A, Al-Baqami F, Alanazi F, Alattar A, Alshaman R, Ur Rehman N
Neurochem Res. 2024; 49(11):3118-3130.
PMID: 39190122
DOI: 10.1007/s11064-024-04226-5.
down-regulation corrects sleep and circadian dysfunction of a Drosophila model of Parkinson's disease.
Favaro M, Mauri S, Bernardo G, Zordan M, Mazzotta G, Ziviani E
Front Neurosci. 2024; 18:1410139.
PMID: 39161651
PMC: 11330830.
DOI: 10.3389/fnins.2024.1410139.
Targeting Catechol-O-Methyltransferase Induces Mitochondrial Dysfunction and Enhances the Efficacy of Radiotherapy in Glioma.
Jiao M, Pirozzi C, Yu C, Bao X, Hu M, Pan D
Cancer Res. 2024; 84(21):3640-3656.
PMID: 39088832
PMC: 11532787.
DOI: 10.1158/0008-5472.CAN-24-0134.
Neuroprotective Effects of Olive Oil: A Comprehensive Review of Antioxidant Properties.
Goncalves M, Vale N, Silva P
Antioxidants (Basel). 2024; 13(7).
PMID: 39061831
PMC: 11274152.
DOI: 10.3390/antiox13070762.
Octadecaneuropeptide, ODN, Promotes Cell Survival against 6-OHDA-Induced Oxidative Stress and Apoptosis by Modulating the Expression of miR-34b, miR-29a, and miR-21in Cultured Astrocytes.
Bourzam A, Hamdi Y, Bahdoudi S, Duraisamy K, El Mehdi M, Basille-Dugay M
Cells. 2024; 13(14.
PMID: 39056770
PMC: 11487398.
DOI: 10.3390/cells13141188.
In Vivo Study of Seed Extracts as Potential Sources of Neuroprotection against Rotenone-Induced Neurotoxicity.
Raza C, Mohsin S, Faheem M, Hanif U, Alkhathlan H, Rafi Shaik M
Plants (Basel). 2024; 13(11).
PMID: 38891288
PMC: 11175126.
DOI: 10.3390/plants13111479.
Novel Gene Therapy Approaches for Targeting Neurodegenerative Disorders: Focusing on Delivering Neurotrophic Genes.
Kumari S, Kamiya A, Karnik S, Rohilla S, Dubey S, Taliyan R
Mol Neurobiol. 2024; 62(1):386-411.
PMID: 38856793
DOI: 10.1007/s12035-024-04260-y.
Oxidative Stress and Neurodegeneration: Insights and Therapeutic Strategies for Parkinson's Disease.
Bej E, Cesare P, Volpe A, dAngelo M, Castelli V
Neurol Int. 2024; 16(3):502-517.
PMID: 38804477
PMC: 11130796.
DOI: 10.3390/neurolint16030037.
The Contribution of Type 2 Diabetes to Parkinson's Disease Aetiology.
Ribaric S
Int J Mol Sci. 2024; 25(8).
PMID: 38673943
PMC: 11050090.
DOI: 10.3390/ijms25084358.
AMPK Signaling Pathway as a Potential Therapeutic Target for Parkinson's Disease.
Athari S, Farajdokht F, Keyhanmanesh R, Mohaddes G
Adv Pharm Bull. 2024; 14(1):120-131.
PMID: 38585465
PMC: 10997932.
DOI: 10.34172/apb.2024.013.